FDA Inspection 1310038 — Allure Labs, LLC

Allure Labs, LLC — FEI 3000204079

The FDA completed an inspection of Allure Labs, LLC on March 27, 2026 in Hayward, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 27, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hayward, CA (United States)

Citations

IDCFRDescription
126321 CFR 211.68(b)Computer control of master formula records
189021 CFR 211.165(e)Test methods
202721 CFR 211.192Investigations of discrepancies, failures